Literature DB >> 11876714

Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study.

P Marteau1, E Cuillerier, S Meance, M F Gerhardt, A Myara, M Bouvier, C Bouley, F Tondu, G Bommelaer, J C Grimaud.   

Abstract

BACKGROUND: A previous study has suggested that Bifidobacterium animalis DN-173 010 shortens the colonic transit time in women. AIM: To confirm this effect and to determine whether modifications of the faecal bacterial mass and/or faecal secondary bile salts may be the explanation.
METHODS: A double-blind, cross-over study was performed. Thirty-six healthy women were studied in four consecutive 10-day periods. During periods 2 and 4, they ingested three 125 g cups per day of a fermented milk which was either a product containing B. animalis DN-173 010 or a control without bifidobacteria. Periods 1 and 3 were run-in and washout periods, respectively. The total and segmental colonic transit times were assessed using a pellet method. In 12 subjects, all stools were collected and analysed for pH, faecal weight, bacterial mass and bile acids.
RESULTS: The total and sigmoid transit times were significantly shorter during dosing with B. animalis compared to the control period. The other transit times, faecal weight, pH, bacterial mass and bile acids were not significantly affected.
CONCLUSIONS: B. animalis DN-173 010 shortens the colonic transit time in healthy women. This effect is not explained by modifications of the faecal bacterial mass or secondary bile acids.

Entities:  

Mesh:

Year:  2002        PMID: 11876714     DOI: 10.1046/j.1365-2036.2002.01188.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  43 in total

1.  Bifidobacterium animalis subsp. lactis ATCC 27673 is a genomically unique strain within its conserved subspecies.

Authors:  Joseph R Loquasto; Rodolphe Barrangou; Edward G Dudley; Buffy Stahl; Chun Chen; Robert F Roberts
Journal:  Appl Environ Microbiol       Date:  2013-08-30       Impact factor: 4.792

2.  Do probiotics improve symptoms in patients with irritable bowel syndrome?

Authors:  Peter J Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 3.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

Review 4.  Contemporary meta-analysis of short-term probiotic consumption on gastrointestinal transit.

Authors:  Larry E Miller; Angela K Zimmermann; Arthur C Ouwehand
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

Review 5.  Abdominal bloating and distension: what is the role of the microbiota.

Authors:  B Issa; N A Wafaei; P J Whorwell
Journal:  Dig Dis Sci       Date:  2011-07-29       Impact factor: 3.199

Review 6.  Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation.

Authors:  Eirini Dimidi; Stephanos Christodoulides; S Mark Scott; Kevin Whelan
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

7.  Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice.

Authors:  James P Moran; Jens Walter; Gerald W Tannock; Susan L Tonkonogy; R Balfour Sartor
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

8.  Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women.

Authors:  Yue-Xin Yang; Mei He; Gang Hu; Jie Wei; Philippe Pages; Xian-Hua Yang; Sophie Bourdu-Naturel
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

9.  A feasibility study of probiotics pretreatment as a bowel preparation for colonoscopy in constipated patients.

Authors:  Hyuk Lee; Young-Ho Kim; Jeong Hwan Kim; Dong Kyung Chang; Jin Yong Kim; Hee Jung Son; Poong-Lyul Rhee; Jae J Kim; Jong Chul Rhee
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

Review 10.  Probiotic products in Canada with clinical evidence: what can gastroenterologists recommend?

Authors:  G Reid; K Anukam; T Koyama
Journal:  Can J Gastroenterol       Date:  2008-02       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.